In 2014, German drug maker Boehringer Ingelheim agreed to pay $650 million to settle approximately 4,000 Pradaxa lawsuits alleging that users suffered severe and often fatal bleeding problems after using the anticoagulant. These settled claims were part of multidistrict litigation (or MDL), that had been ongoing since April 2012 in the U.S. District Court for the...
New Pradaxa Bleeding Lawsuits Being Filed in Connecticut State Court
